Kliničke studije za Гојазност u državi Њујорк
73 studija za Гојазност traži učesnike na lokacijama u državi Њујорк.
Gradovi u državi Њујорк
- New York City39 студија
- Rochester14 студија
- Buffalo10 студија
- Brooklyn6 студија
- Syracuse6 студија
- The Bronx5 студија
- Albany4 студија
- Manhattan3 студија
Zvanični tekst studije (na engleskom)
Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
- Equity Medical, LLC, The Bronx
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07830329Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07144800Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Rochester Clinical Research, Rochester
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 9. 11. 2026. · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Rochester Clinical Research, Buffalo
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351045Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- NYC Research Inc, New York
- Rochester Clinical Research, Rochester
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Icahn School of Medicine at Mount Sinai, New York
- Rochester Clinical Research, Rochester
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Rochester Clinical Research, Inc, Rochester
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07843498A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- NYC Research, New York
- IMA Clinical Research NYC Midtown, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Equity Medical, New York
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- UBMD Pediatrics, Buffalo
Тражи се учесникФаза 3
Узраст од 6 до 11 · Оба пола · Ажурирано 4. 11. 2026. · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NYC Research INC, Long Island City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- NYU Langone Health, New York
- Weill Cornell Medical College, New York
- IMA Clinical Research Manhattan, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Ellipsis Research Group - Brooklyn - 7th Street, Brooklyn
- Rochester Clinical Research - Buffalo, Buffalo
- NYC Research INC, Long Island City
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Rochester Clinical Research - Buffalo, Buffalo
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- UBMD Pediatrics, Buffalo
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- NYC Research INC, Long Island City
- Richmond University Medical Center, Staten Island
- Southgate Medical Group, West Seneca
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Rochester Clinical Research - Buffalo, Buffalo
- CHEAR Center LLC, The Bronx
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802Time Restricted Eating for WeIght LoSs MainTenance-2
- NYU Langone Health, New York
Тражи се учесник
Узраст од 25 до 65 · Оба пола · Ажурирано 2. 11. 2026. · NCT07190170A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Cortland
- Research Site, Rochester
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Capital Cardiology Associates, Albany
- Icahn School of Medicine at Mount Sinai, New York
- Hudson Valley Cardiovascular Practice PC, Poughkeepsie
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Rochester Clinical Research /ID# 282484, Rochester
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- ALSA Research-Manhattan, New York
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Albany
- ACCOMPLISH-2 Research Site, Albany
- ACCOMPLISH-2 Research Site, Brooklyn
- и још 1
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Weill Cornell Medicine, New York
Тражи се учесник
Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669Effects of Ultra Processed Food on Intestinal Energy Harvest
- Columbia University Irving Medical Center, New York
Тражи се учесник
Узраст 25 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06853288Blood Collection Biorepository for Liver Disease Research
- University at Buffalo, Buffalo General Medical Center, Buffalo
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 7 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT03025074A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Dent Neurologic Institute, Amherst
- Rochester Clinical Research, LLC, Rochester
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Dent Neurologic Institute, Amherst
- Velocity Clinical Research, Syracuse, East Syracuse
- Rochester Clinical Research, LLC, Rochester
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT06143956AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Weil Cornell Medicine, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07571109Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research- Binghamton, Binghamton
- Rochester Clinical Research, Rochester
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684235Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
- State University of New York at Buffalo, South Campus, Buffalo
Тражи се учесник
Узраст од 18 до 60 · Оба пола · Ажурирано 2. 10. 2026. · NCT07641361Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
- Weill Cornell -1300 York Avenue, New York
- Lenox Hill Hospital | Northwell Health, New York
Тражи се учесник
Узраст од 21 до 65 · Оба пола · Ажурирано 1. 10. 2026. · NCT07090005A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- UBMD Physicians Group - Pediatrics - Conventus, Buffalo
- SUNY Upstate Medical Univ - Syracuse, Syracuse
- Advantage Clinical Trials, The Bronx
Тражи се учесникФаза 3
Узраст од 8 до 18 · Оба пола · Ажурирано 30. 9. 2026. · NCT07253285AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Comprehensive Weight Ctrl Prog, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Ichor Research, Syracuse
- Southgate Medical Group, LLP, West Seneca
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07668414AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- New York Gastroenterology Associates, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT07339423A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Rochester Clinical Research, LLC, Rochester
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07321886Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.